Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Ранг среди акций #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Цена акции
$0.117
Последняя синхронизация: 2025-04-04
Рыночная капитализация
$2.45M
Изменение (1 день)
-13.59%
Изменение (1 год)
0.00%
Страна
US
Торговля Carmell Therapeutics Corporation (CTCX)

Категория

EPS для Carmell Therapeutics Corporation (CTCX)
EPS по состоянию на June 2026 TTM: $-4.71
Согласно последним финансовым отчетам и цене акций Carmell Therapeutics Corporation, текущий EPS компании (TTM) составляет $-4.71. В конце 2023 EPS компании составлял $-0.74, больше, чем показателю 2022 года, равному $-0.50.
История EPS компании Carmell Therapeutics Corporation с 2021 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -467.73%
US
$27.74 -688.96%
NL
- -
CH
- -
KR
$13.70 -390.87%
BE